Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease

doi:10.3748/wjg.v31.i18.104206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (218)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

HTML

157

Figures (1-3)

Tables (1-5)

Sum=194

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=12

May 14, 2025 (publication date) through May 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 14, 2025; 31(18): 104206
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.104206

Full Size Figure Download Figure

Figure 3 The receiver operating characteristic curve of the ulcerative colitis and Crohn’s disease validation set. A: The receiver operating characteristic curve of the ulcerative colitis validation set; B: The receiver operating characteristic curve of the Crohn’s disease validation set. ESR: Erythrocyte sedimentation rate; CAR: C-reactive protein/albumin; PAR: Platelet/albumin; AGR: Albumin/globulin.

Citation: Liu X, Pan LX, Pei JX, Pu T, Wen HT, Zhao Y. Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease. World J Gastroenterol 2025; 31(18): 104206
URL: https://www.wjgnet.com/1007-9327/full/v31/i18/104206.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i18.104206